Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer

被引：0
|
作者：
Xiaobin Gu
Meilian Dong
Zheyan Liu
Yin Mi
Jing Yang
Zhigang Zhang
Ke Liu
Li Jiang
Yue Zhang
Shiliang Dong
Yonggang Shi
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Radiation Oncology
[2] Zhengzhou University,undefined
来源：
Cancer Cell International | / 19卷
关键词：
Cervical cancer; PD-L1; Meta-analysis; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Programmed death ligand (PD-L1) expression and survival outcome in radically treated cervical cancer
    Prakasan, A. Mullangath
    S, L.
    L, A. S.
    Ramadas, P. T.
    Kumar, A.
    Mathews, S.
    Joseph, J.
    George, J.
    Mathew, A.
    James, F. V.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1146 - S1147
  • [22] Examining the Association between PD-L1 Expression and Clinicopathological Features and Survival Outcomes in Australian Urothelial Cancer Patients
    Cui, Wanyuan
    Phuong Phan
    Goz, Kubra
    Corrente, Claudia
    Baenziger, Olivia N.
    Dundee, Phil
    Zargar, Homi
    Anderson, Paul
    Lawrentschuk, Nathan
    Gibbs, Peter
    Ischia, Joseph
    Weickhardt, Andrew
    Wong, Lih-Ming
    Cernelc, Janez
    Fox, Stephen
    Sengupta, Shomik
    Tran, Ben
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 45 - 46
  • [23] PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients
    Goltz, Diane
    Gevensleben, Heidrun
    Dietrich, Joern
    Dietrich, Dimo
    ONCOIMMUNOLOGY, 2017, 6 (01):
  • [24] A Radiomics Approach for Prediction of PD-L1 Expression in Cervical Cancer Patients: An Initial Result
    Cai, M.
    Tang, H.
    Tan, X.
    Guo, W.
    Li, Y.
    Ma, Y.
    Xu, W.
    Zhu, X.
    Luo, J.
    Liu, Z.
    Chen, H.
    Lu, J.
    Zhang, Y.
    Shi, F.
    Wang, J.
    Su, J.
    Ma, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E452 - E453
  • [25] Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line
    Zhao, Yue
    Mao, Yousheng
    He, Jie
    Gao, Shugeng
    Zhang, Zhirong
    Ding, Ningning
    Xue, Qi
    Gao, Yushun
    Wang, Dali
    Zhao, Jun
    Tan, Fengwei
    Yuan, Ligong
    Li, Feng
    Wang, Shuaibo
    Yang, Lin
    CLINICAL LUNG CANCER, 2021, 22 (02) : E201 - E210
  • [26] PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival
    Micevic, Goran
    Thakral, Durga
    McGeary, Meaghan
    Bosenberg, Marcus W.
    PIGMENT CELL & MELANOMA RESEARCH, 2019, 32 (03) : 435 - 440
  • [27] PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer
    Wang Xinran
    Liu, Yueping
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (03)
  • [28] PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential
    Rotman, Jossie
    Otter, Leontine A. S. den
    Bleeker, Maaike C. G.
    Samuels, Sanne S.
    Heeren, A. Marijne
    Roemer, Margaretha G. M.
    Kenter, Gemma G.
    Zijlmans, Henry J. M. A. A.
    van Trommel, Nienke E.
    de Gruijl, Tanja D.
    Jordanova, Ekaterina S.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [29] PD-L1 Expression Is Associated With VEGFA and LADC Patients' Survival
    Liu, Shaochuan
    Qin, Tingting
    Jia, Yanan
    Li, Kai
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [30] PD-1 and PD-L1 Expression Predicts Radiosensitivity and Clinical Outcomes in Head and Neck Cancer and is Associated with HPV Infection
    Lyu, Xintong
    Zhang, Miao
    Li, Guang
    Jiang, Yuanjun
    Qiao, Qiao
    JOURNAL OF CANCER, 2019, 10 (04): : 937 - 948
12345